STOCK TITAN

PetVivo Holdings (PETV) director buys 50,000 restricted shares in private deal

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Rudelius Robert James reported acquisition or exercise transactions in this Form 4 filing.

PetVivo Holdings director Robert James Rudelius purchased 50,000 shares of restricted common stock in a private sale. On April 15, 2026, he bought these shares from another PetVivo shareholder at $0.40 per share, bringing his direct holdings to 403,392 common shares. He also reports indirect ownership of 21,000 common shares held by a corporation.

Positive

  • None.

Negative

  • None.
Insider Rudelius Robert James
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 50,000 $0.40 $20K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 403,392 shares (Direct); Common Stock — 21,000 shares (Indirect, By corporation)
Footnotes (1)
  1. [object Object]
Shares purchased 50,000 shares Restricted common stock bought in private sale on April 15, 2026
Purchase price $0.40 per share Price paid for 50,000 restricted common shares
Direct holdings after transaction 403,392 shares Common stock directly owned by Rudelius after acquisition
Indirect holdings 21,000 shares Common stock held indirectly by corporation associated with Rudelius
restricted common stock financial
"Represents a purchase of 50,000 shares of PetVivo Holdings, Inc. restricted common stock"
Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.
private sale financial
"restricted common stock ("Shares") by the Reporting Person in a private sale from another shareholder"
indirect ownership financial
"total_shares_following_transaction": "21000.0000" ... "nature_of_ownership": "By corporation""
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rudelius Robert James

(Last)(First)(Middle)
5151 EDINA INDUSTRIAL BLVD., SUITE 575

(Street)
EDINA, MINNESOTA 55439

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PetVivo Holdings, Inc. [ PETV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/15/2026A50,000(1)A$0.4403,392D
Common Stock21,000IBy corporation
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a purchase of 50,000 shares of PetVivo Holdings, Inc. restricted common stock ("Shares") by the Reporting Person in a private sale from another shareholder of PetVivo Holdings, Inc.
/s/ Robert Rudelius04/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PetVivo (PETV) report for Robert James Rudelius?

PetVivo reported that director Robert James Rudelius purchased 50,000 shares of restricted common stock. The shares were acquired in a private sale from another PetVivo shareholder at $0.40 per share on April 15, 2026, increasing his direct ownership stake.

At what price did the PetVivo (PETV) director buy the 50,000 shares?

The 50,000 restricted common shares were purchased at $0.40 per share. This private transaction, disclosed in a Form 4 filing, involved buying the shares from another existing PetVivo shareholder rather than through the open market or an options exercise.

How many PetVivo (PETV) shares does Robert James Rudelius now hold directly?

After the reported transaction, Robert James Rudelius holds 403,392 PetVivo common shares directly. The Form 4 filing shows this post-transaction balance, reflecting the addition of the 50,000 restricted shares acquired in the private purchase from another shareholder.

Does the PetVivo (PETV) director have any indirect share ownership?

Yes. In addition to his direct holdings, the filing shows 21,000 PetVivo common shares held indirectly. These shares are owned "By corporation," indicating an entity-associated interest separate from his personally held 403,392 direct shares reported after the transaction.

Was the PetVivo (PETV) share acquisition a grant or a private purchase?

Although coded as an acquisition in the Form 4, the footnote clarifies it was a private purchase. Rudelius bought 50,000 restricted common shares from another shareholder in a private sale, rather than receiving them as an equity grant or compensation award from PetVivo.